Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details)

v3.23.3
Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Aug. 31, 2023
Aug. 31, 2022
May 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity method investments, total losses $ 12.3 $ 1,060.3 $ 135.8 $ 1,060.3  
Corporate Venture Capital, Equity Method Investments          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity method investments, carrying value 14.9   14.9    
Equity method investments 2.6   2.6    
Equity method investments, total losses $ 12.3   12.3    
Canopy Equity Method Investment          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity method investments, carrying value   1,695.1   1,695.1 $ 266.2
Equity method investments   634.8   634.8 $ 142.7
Equity method investments, total losses   $ 1,060.3 $ 123.5 $ 1,060.3